Table 4. Model validation and survival data after ten year, 1000 subject trial.
Variable | No transplant available |
Listed for DDLT |
Listed for DDLT with LDLT available |
---|---|---|---|
Mean cost per patient, 2002 USD | 65,068 | 151,613 | 208,149 |
Mean unadjusted lifespan (years) | 3.1 | 6.4 | 7.3 |
Mean quality adjusted lifespan (QALY) | 1.9 | 4.4 | 4.9 |
Number receiving DDLT (primary or retransplant) | - | 687 | 233 |
Number receiving LDLT (primary) | - | - | 715 |
Number dead after 1 year | 175 | 158 | 136 |
Number dead after 5 years | 630 | 335 | 256 |
Number dead after 10 years | 964 | 454 | 397 |
Number receiving primary transplant at one year | - | 309 | 520 |
Number receiving primary transplant at five years | - | 516 | 662 |
Number dead pre-transplant or on waitlist* (%) | 964 | 309 (30.9) | 112 (11.2) |
Mean cost to prevent one pre-transplant death, 2002 USD | - | 122,516 | 199,942 |
Number dead after transplant (%) | - | 145 (14.5) | 285 (28.5) |
Living donor deaths (%) | - | - | 2 (0.2) |
Living donor serious complications, excluding deaths (%) | - | - | 17 (2.4) |
This represents a 10 year cumulative mortality for the entire cohort. The yearly mortality rate on the waiting list is roughly one-tenth of this value.